The iCARUS clinical trial demonstrated a 96.4% primary patency rate at 9 months, showing the device is highly effective for vascular treatment.
The iCast is a balloon-expandable stent system designed to support and hold open structures within the body. g60511.mp4
may occur if used in patients with active inflammation or infections. The iCARUS clinical trial demonstrated a 96